Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.

Malignant B-cells from most chronic lymphocytic leukaemia (CLL) patients over-express MDR1 encoded P-glycoprotein (P-gp) multidrug efflux pump. Inhibition of glucosylceramide (GC) synthesis has been shown in cell lines to correlate with the expression and function of P-gp and sensitise cancer cells...

全面介紹

書目詳細資料
Main Authors: Gerrard, G, Butters, T, Ganeshaguru, K, Mehta, AB
格式: Journal article
語言:English
出版: 2009